- Both the National Institutes of Health and the National Science Foundation are facing funding cuts, coinciding with a discussion by Sally Kornbluth about NSF-funded research.
- The Trump administration implemented viewpoint-based grant cuts and political screening mechanisms at NSF and NIH, leading to legal challenges.
The NIH is seeking control over federal research funding, implementing a right-wing vision, and awarding grants to academic researchers.
2 reports, 2 independent
Updated Sep 21
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The NIH is seeking control over federal research funding, implementing a right-wing vision, and awarding grants to academic researchers.
Who's involved
What this event is mainly aboutKeep exploring
Part of
The Trump administration implemented viewpoint-based grant cuts and political screening mechanisms at NSF and NIH, leading to legal challenges.Also in this story
- The ACLU filed a lawsuit against NIH policies as the administration blocks and cancels scientific grants.
- Moorpark College faced program cuts after the Trump administration ended Hispanic-Serving Institution grants.
- Kevin Cramer is holding nominees for the National Science Foundation, pending administration changes to the wetland program, representing North Dakota interests.
The entities involved
-
National Institutes of Health
government organization in Shah Alam, Malaysia
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- Donald Trump discussed policy that was informed by insights from justice institutes.
- Donald Trump proposed significant budget cuts to the National Science Foundation.
- The National Institutes of Health requires increased federal budget funding, with research demonstrating a potential $2.50 return on investment, discussed alongside U.S. Senator McCormick.
- NIH cuts budgets and personnel, impacting funded research leading to FDA-approved treatments.